Listing 1 - 10 of 11 | << page >> |
Sort by
|
Choose an application
Cet ouvrage traite de la production de Joao Mendes Ribeiro, architecte portugais né en 1960, pour la période qui va de 2003 à 2016, durant laquelle l'architecte a réalisé de nombreuses rénovations et transformations afin de réhabiliter des bâtiments existants.
Architecture --- 72.07 --- 72.039(469) --- Mendes Ribeiro, João °1960 (°Coimbra, Portugal) --- Architectuur ; 21ste eeuw ; 2003-2016 ; J.Mendes Ribeiro --- Architecture, Western (Western countries) --- Building design --- Buildings --- Construction --- Western architecture (Western countries) --- Art --- Building --- History --- Architecten. Stedenbouwkundigen A - Z --- Architectuurgeschiedenis ; 2000 - 2050 ; Portugal --- Design and construction --- Ribeiro, João Mendes. --- Mendes Ribeiro, João --- Mendes Ribeiro, Joao --- Portugal --- Rénovation architecturale --- Architecture, Primitive
Choose an application
HIV/AIDS continues to be one of the most challenging individual and public health concerns of the present day. According to the UNAIDS, nearly 38 million individuals were living with the infection by the end of 2018, while 1.7 million new cases occurred during that same year. In spite of the numerous advances in the development and delivery of antiretroviral agents, both for treatment and prevention, several challenges remain. This book includes original research and review articles on innovative strategies and approaches for the formulation and delivery of anti-HIV drugs, including genetic material and other biopharmaceuticals. Different local and systemic delivery strategies are addressed based on different technologies intended for oral, transdermal, subcutaneous, vaginal, or rectal administration. Authored by eminent scientists in academia and nonprofit organizations involved in the development of antiretroviral drug products, this collection provides useful information for all those involved in HIV/AIDS treatment and prevention.
Anti-HIV Drugs --- HIV --- AIDS
Choose an application
Pitágoras Arquitectos is an architectural firm based in Portugal with 20 years of experience. It’s growing team is now made up of 14 people, led by its four senior architectural partners, Fernando Seara de Sá, Raul Roque Figueiredo, Alexandre Coelho Lima and Manuel Vilhena Roque. In collaboration with external partners, it creates an overall multidisciplinary team that embraces every comission, local or international, large or small, to meet client expectatons and desires, always founded on strong architectural principles and ethics. An interdisciplinary practice that works all architectural fields: from interior design to urban planning, including residential, health and equipment for both the private and public sector, developing projects from concept design through to tender packages and field management.
Choose an application
Choose an application
Choose an application
Choose an application
This book provides a concise and up-to-date overview of the biological features justifying the use of different human mucosa as delivery routes for biopharmaceuticals as well as the technological strategies that have been followed so far regarding the optimization of mucosal potentialities. The book also addresses the challenges that arise with the advent of new biopharmaceutical drugs and alternative means of administration. After a brief introduction, the first section addresses general aspects of the biology of mucosal tissues and their unique aspects towards beneficial or deleterious interactions with biopharmaceuticals and delivery systems. The second part is dedicated to the different delivery strategies that have recently been investigated for different mucosal sites. The third section describes the development and clinical applications, either factual or potential, of particular pharmaceutical delivery systems and products enclosing biopharmaceuticals for mucosal delivery. Special focus is set on the most successful case studies of recent years by field experts or those engaged in developing such solutions in a concise and practical way. The last section briefly centers on pertinent aspects about the regulatory, toxicological and market issues of mucosal delivery of biopharmaceuticals. José das Neves is a researcher at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, and in the Faculty of Pharmacy, University of Porto, Portugal, where he earned a Ph.D. in Pharmaceutical Sciences. His previous work has spanned multiple aspects of the development of vaginal drug delivery systems, and his current research interests include the development of nanotechnology-based solutions for the development of anti-HIV microbicides and mucosal delivery of biopharmaceuticals. Bruno Sarmento is an affiliated researcher at INEB – Instituto de Engenharia Biomédica, University of Porto, Portugal. He is also an assistant professor of pharmaceutical and biopharmaceutical technology at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, Portugal. He earned a Ph.D. in Pharmaceutical Technology at the University of Porto. He has extensive work in the development of nanocarriers for the oral delivery of biopharmaceuticals—namely insulin—and the establishment of novel in vitro intestinal permeability models. His current research focuses on nanomedicines and their applications in the pharmaceutical and biomedical fields.
Biomedicine. --- Biopharmaceutics. --- Medicine. --- Pharmaceutical technology. --- Pharmacology. --- Toxicology. --- Drug delivery systems --- Mucous membrane --- Biopharmaceutics --- Membranes --- Immunity --- Drug Administration Routes --- Pharmacology --- Investigative Techniques --- Drug Therapy --- Metabolic Phenomena --- Health Occupations --- Immune System Phenomena --- Tissues --- Phenomena and Processes --- Biological Science Disciplines --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Therapeutics --- Disciplines and Occupations --- Anatomy --- Natural Science Disciplines --- Drug Delivery Systems --- Methods --- Administration, Mucosal --- Immunity, Mucosal --- Metabolism --- Mucous Membrane --- Health & Biological Sciences --- Pharmacy, Therapeutics, & Pharmacology --- Drugs --- Biological transport. --- Drug delivery systems. --- Physiological transport. --- Methodology. --- Delivery systems, Drug --- Drug administration technology --- Drug delivery technology --- Membrane transport --- Passive transport, Biological --- Physiological transport --- Transport, Biological --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Delivery systems --- Pharmaceutical Sciences/Technology. --- Pharmacology/Toxicology. --- Pharmaceutical technology --- Diffusion --- Osmosis --- Pharmacy --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Chemicals --- Medicine --- Poisoning --- Poisons --- Pharmaceutical laboratory techniques --- Pharmaceutical laboratory technology --- Technology, Pharmaceutical --- Technology --- Toxicology --- Drug effects --- Medical pharmacology --- Medical sciences --- Physiological effect
Choose an application
This book provides a concise and up-to-date overview of the biological features justifying the use of different human mucosa as delivery routes for biopharmaceuticals as well as the technological strategies that have been followed so far regarding the optimization of mucosal potentialities. The book also addresses the challenges that arise with the advent of new biopharmaceutical drugs and alternative means of administration. After a brief introduction, the first section addresses general aspects of the biology of mucosal tissues and their unique aspects towards beneficial or deleterious interactions with biopharmaceuticals and delivery systems. The second part is dedicated to the different delivery strategies that have recently been investigated for different mucosal sites. The third section describes the development and clinical applications, either factual or potential, of particular pharmaceutical delivery systems and products enclosing biopharmaceuticals for mucosal delivery. Special focus is set on the most successful case studies of recent years by field experts or those engaged in developing such solutions in a concise and practical way. The last section briefly centers on pertinent aspects about the regulatory, toxicological and market issues of mucosal delivery of biopharmaceuticals. José das Neves is a researcher at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, and in the Faculty of Pharmacy, University of Porto, Portugal, where he earned a Ph.D. in Pharmaceutical Sciences. His previous work has spanned multiple aspects of the development of vaginal drug delivery systems, and his current research interests include the development of nanotechnology-based solutions for the development of anti-HIV microbicides and mucosal delivery of biopharmaceuticals. Bruno Sarmento is an affiliated researcher at INEB – Instituto de Engenharia Biomédica, University of Porto, Portugal. He is also an assistant professor of pharmaceutical and biopharmaceutical technology at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, Portugal. He earned a Ph.D. in Pharmaceutical Technology at the University of Porto. He has extensive work in the development of nanocarriers for the oral delivery of biopharmaceuticals—namely insulin—and the establishment of novel in vitro intestinal permeability models. His current research focuses on nanomedicines and their applications in the pharmaceutical and biomedical fields.
Toxicology --- Pharmacology. Therapy --- Pathological biochemistry --- Human medicine --- klinische chemie --- medische biochemie --- farmacologie --- biogeneesmiddelen --- biochemie --- biomedische wetenschappen --- multimedia --- toxicologie
Choose an application
Industries --- History
Choose an application
Architecture --- architectuur --- Serôdio, João Pedro --- Furtado, Isabel --- architecture [discipline]
Listing 1 - 10 of 11 | << page >> |
Sort by
|